BELOTERO® LIPS CONTOUR LIDOCAINE 0,6ML

Belotero Lips Contour Lidocaine is a cross-linked hyaluronic dermal filler designed to treat lip contouring and provide fullness to the lips. Belotero Lips Contour is ideal to restore the outline of the lips for a more youthful appearance. The product contains lidocaine, which reduces the pain level and ensure a more comfortable treatment for the patient.

Additionally, Belotero Lips Contour is part of a duo for subtle and natural lip enhancements.

The pack consists of:

• 1 x 0,6ml syringe
• 1 x 27G ½” Needle
• 1 x 30G ½” Needle

The composition of Belotero Lips Contour:

• 22,5 mg/ml Hyaluronic acid
• 0,3 Lidocaine

Benefits of Belotero Lips Contour:

• Balance the lip shape
• Enhanced curves and contours
• Natural long-lasting results

How long does the result last for?

The duration depends on the individual’s lifestyle, age and skin type

Who should not use BELOTERO BALANCE?

BELOTERO BALANCE should not be used in patients with a history of or presence of multiple or severe allergies, including those with a history of anaphylaxis. BELOTERO BALANCE should not be used in patients with allergies to gram-positive bacterial proteins..

What is the most important information I should know about BELOTERO BALANCE?

Introduction of BELOTERO BALANCE into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting soft tissue fillers, for example inject the product slowly and apply the least amount of pressure necessary. Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms, including changes in vision, signs of a stroke, blanching of the skin, or unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and possibly evaluation by an appropriate health care practitioner specialist should an intravascular injection occur.

THE ORIGIN OF THIS PRODUCT IS FROM THE EUROPEAN COMMUNITY (EC)